PMV Pharmaceuticals

-$0.12 (-0.34%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell PMVP and other stocks, options, and ETFs commission-free!

About PMVP

PMV Pharmaceuticals, Inc. engages in the development of p53 targeted small molecule drugs for the treatment of cancer. It combines unique biological understanding with pharmaceutical development focus.

CEO
David H. Mack
Employees
44
Headquarters
Cranbury, New Jersey
Founded
2013

PMVP Key Statistics

Market Cap
1.52B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
159.26K
High Today
$35.50
Low Today
$34.30
Open Price
$35.04
Volume
112.35K
52 Week High
$63.22
52 Week Low
$29.45

PMVP Earnings

-$1.46
$0.20
$1.87
$3.53
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, After Hours

You May Also Like

IPVIW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure